Higher-quality trials find no skin benefit from collagen supplements

A 2025 meta-analysis of 23 randomized trials found no improvement in skin hydration, elasticity or wrinkles when researchers examined higher-quality studies separately. Favorable results were concentrated in lower-quality and pharmaceutical-company-funded trials, leaving the clinical case for collagen supplements unresolved.

The result helps explain why consumers encounter apparently conflicting claims. Earlier pooled analyses reported benefits, but pooling alone can conceal differences in study quality, funding and product formulation.

When symptoms need urgent care

Stop taking a supplement and seek emergency medical help if the lips, mouth, throat or tongue suddenly swell, breathing becomes difficult, the throat feels tight, or fainting or sudden confusion occurs. The United Kingdom's National Health Service identifies these as signs of a serious allergic reaction that may require immediate hospital treatment.

The American Academy of Dermatology says collagen products may contain seafood-derived ingredients, many lack clear ingredient information, and people with underlying conditions should discuss supplements with a dermatologist. People with known food allergies need to check the full ingredient list. Children, pregnant or breastfeeding people, anyone with a chronic condition, and people taking regular medicines should discuss a supplement with a clinician or pharmacist rather than applying results from generally healthy adult trial participants to themselves.

Earlier pooled evidence appeared favorable

A 2021 systematic review and meta-analysis pooled 19 randomized, double-blind controlled trials with 1,125 participants and reported improvements in hydration, elasticity and wrinkles. The participants were aged 20 to 70, and 95 percent were women.

That analysis helped support broad marketing claims, but its pooled result did not answer whether funding or trial quality tracked with the reported effects. It also did not establish that every collagen source, formulation or dose would produce the same outcome.

The 2025 analysis changed the interpretation

The 2025 review assessed 23 randomized trials involving 1,474 participants and analyzed skin hydration, elasticity and wrinkles by funding source and study quality. When all trials were pooled, collagen supplements appeared to improve the three outcomes.

The subgroup results were different. Studies without pharmaceutical-company funding found no effect on any of the three outcomes, while funded studies reported benefits. The highest-quality studies likewise found no effect across hydration, elasticity or wrinkles; lower-quality studies produced favorable findings for some measures.

The authors concluded that current clinical evidence does not support collagen supplements for preventing or treating skin aging. That conclusion is narrower than saying no formulation could ever work: it says the available positive evidence did not hold up in the more reliable subgroups.

Absorption and laboratory mechanisms do not prove a skin benefit

A biological pathway can be plausible without producing a measurable clinical effect. Evidence that digestion leaves amino acids or small peptides, or that a compound changes cultured skin cells, answers a mechanism question. It does not show that taking a supplement improves wrinkles, hydration or elasticity in people.

Clinical claims therefore need randomized comparisons against a placebo, measurements selected before results are known, adequate follow-up and transparent reporting of funding. A product cannot borrow a benefit from a study if its ingredients, formulation or tested outcome differ from those in the trial.

How to read a collagen claim

Start with the outcome. “Supports collagen production” is not the same claim as a visible or measured reduction in wrinkles. A report should state what was measured, how large the difference was, how long the trial lasted and whether the comparison was against a placebo.

Funding and study quality belong alongside the headline result. A positive pooled estimate can change when researchers separate trials by risk of bias or financial support, as the 2025 analysis showed. Testimonials and laboratory findings cannot replace that clinical comparison.

The American Academy of Dermatology describes evidence for collagen and other beauty supplements as inconsistent. It also notes that many collagen products lack independent verification of their contents.

No single research dose can serve as a universal recommendation because products and regulations vary by country. The cited evidence does not establish long-term benefit or safety for children, pregnancy, breastfeeding, chronic illness or use alongside prescription medicines.

Frequently asked questions

Do collagen supplements improve skin hydration or wrinkles?
The full pool of trials in the 2025 meta-analysis favored collagen, but the benefit disappeared in studies without pharmaceutical-company funding and in the highest-quality studies. The authors said current clinical evidence does not support use for preventing or treating skin aging.

Does absorption prove that collagen reaches the skin?
No. Detecting digestion products in blood would establish absorption, not an improvement in skin appearance or function. That outcome requires a well-controlled human trial with a relevant skin measure.

Why can two meta-analyses reach different conclusions?
Reviews can include different trials or analyze the same evidence differently. The 2021 review reported favorable pooled results, while the 2025 review tested whether funding and methodological quality changed the pattern and found that they did.

Should someone take a collagen supplement?
The evidence does not support presenting collagen as a proven treatment for skin aging. Anyone considering a product should check its ingredients and evidence rather than assume that a mechanism study or general collagen claim applies to that formulation.